SCHEMBL30299156

SCHEMBL30299156

c1cncc(NCC2C3CC4CC(C3)CC2C4)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
USP2 O75604 1/20 0.45
KMT2A Q03164 1/20 0.45
RAB9A P51151 1/20 0.42
P2RX7 Q99572 2/20 0.42
EPHX2 P34913 1/20 0.42
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GRIN2B Q13224 1/20 0.39
LTA4H P09960 1/20 0.38
CXCR3 P49682 1/20 0.38
CRHR1 P34998 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA7 P36544 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19198139 1.00 MEN1 (0.45) MEN1USP2KMT2ARAB9AP2RX7
SCHEMBL19198145 0.72 MEN1 (0.62) MEN1USP2KMT2ARAB9AP2RX7
SCHEMBL6778508 0.71 GBA1 (0.51) RAB9ACYP3A4CYP2D6CYP2C9SMN1; SMN2
SCHEMBL8623490 0.70 KDM4E (0.39) MEN1KMT2AP2RX7EPHX2CYP3A4
Hydrochloric Acid SCHEMBL21641310 0.70 CYP3A4 (0.44) RAB9ACYP3A4CYP2D6CYP2C9GRIN2B
SCHEMBL4037864 0.69 KCNH3 (0.56) RAB9ACYP3A4CYP2D6CYP2C9GRIN2B
SCHEMBL12531359 0.69 KDM1A (0.50) RAB9ACYP3A4CYP2D6CYP2C9GRIN2B
SCHEMBL3363335 0.69 SMN1; SMN2 (0.65) P2RX7CYP2D6SMN1; SMN2LTA4HCYP1A2
SCHEMBL13493771 0.69 CYP3A4 (0.49) KMT2ARAB9ACYP3A4CYP2D6CYP2C9
SCHEMBL20724728 0.68 EPHX2 (0.60) MEN1USP2KMT2ARAB9AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286917-A1 HISTONE DEMETHYLASE INHIBITORS CELGENE QUANTICEL RESEARCH, INC. (US) 2023-09-14 US disclosed
US-11639333-B2 Histone demethylase inhibitors CELGENE QUANTICEL RESEARCH, INC (US) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286917-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM5A, KDM1A MEN1 1315/4885USP2 485/4885KMT2A 45/4885
US-11639333-B2 Histone demethylase inhibitors KDM1B, KDM5A, KDM1A MEN1 1315/4885USP2 485/4885KMT2A 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.